AUPH β€” AURINIA PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd  Β·  9 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in AURINIA PHARMACEUTICALS INC (AUPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.06% (2022 Q4)
πŸ“Š Avg. % of fund
0.04%
πŸ“… First filed
2022 Q2
πŸ“… Last filed
2025 Q3
⏱ Quarters held
9

Position Intelligence

XTX Topco Ltd Γ— AUPH AI Analytics

πŸ“ˆ XTX Topco Ltd outperformed the S&P 500 by +19.6% annually on this AUPH position. Timing score: 38% (3/8 decisions correct). Average cost basis: $7.41. Maximum drawdown during holding period: –57.0%.

πŸ“ˆ Position Alpha vs SPY
+19.6%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 19.6% per year on this position.
8 quarters analyzed

⏱️ Timing Score
38%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
3 of 8 add/trim decisions correct

πŸ’° Entry Quality
$7.41
+49.1% vs current ($11.05)

Best entry: $4.32 (2022 Q4)  Β·  Worst: $10.05 (2022 Q2)

πŸ›‘οΈ Drawdown Resilience
–57.0%
max drawdown while held

πŸ’ͺ Held through 2 major drawdowns (>20%).

πŸ’ͺ Fund Conviction
67%
buy-side decisions

6 adds Β· 3 trims. Bought during 4 of 5 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.01% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    AUPH price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 21,686 -84,749 -79.6% 0.01% $240K $11.05
2025 Q1 ADDED 106,435 +63,681 +148.9% 0.04% $856K $8.04
2024 Q4 ADDED 42,754 +19,263 +82.0% 0.03% $384K $8.98
2024 Q1 REDUCED 23,491 -770 -3.2% 0.02% $118K $5.01
2023 Q3 ADDED 24,261 +10,700 +78.9% 0.03% $189K $7.77
2023 Q2 REDUCED 13,561 -54,982 -80.2% 0.02% $131K $9.68
2022 Q4 ADDED 68,543 +35,790 +109.3% 0.06% $296K $4.32
2022 Q3 ADDED 32,753 +19,502 +147.2% 0.06% $246K $7.52
2022 Q2 INITIATED 13,251 β€” β€” 0.05% $133K $10.05

🏒 Other funds also holding AUPH

As of 2025 Q4 β€” sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 8.93% KOTLER KEVIN 4.57% NEA Management Company, LLC 3Y 7Y 3.23% nVerses Capital, LLC 0.91% IRONWOOD INVESTMENT MANAGEMENT LLC 3Y 7Y 0.77% Neo Ivy Capital Management 3Y 7Y 0.58% Uniplan Investment Counsel, Inc. 3Y 7Y 0.54% PSP Research LLC 0.47% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.44% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.4%
← Back to XTX Topco Ltd Holdings